Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 7
Submit an article Journal homepage
1,354
Views
34
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Myeloid/lymphoid neoplasms with FGFR1 rearrangement

Paolo StratiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Guilin TangDepartment of HematopathologyThe University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Dzifa Y. DuoseDepartment of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA; View further author information
,
Saradhi MallampatiDepartment of HematopathologyThe University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Rajyalakshmi LuthraDepartment of HematopathologyThe University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Keyur P. PatelDepartment of HematopathologyThe University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Mohammad HussainiDepartment of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA; View further author information
,
Abu-Sayeef MirzaDepartment of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA; View further author information
,
Rami S. KomrokjiDepartment of Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA; View further author information
,
Stephen OhDepartment of Hematology, Washington University School of Medicine, St Louis, MO, USA; View further author information
,
John MascarenhasDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; View further author information
,
Vesna NajfeldDepartment of Pathology IcahnSchool of Medicine at Mount Sinai, New York, NY, USA; View further author information
,
Vivek SubbiahDepartment of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttp://orcid.org/0000-0002-6064-6837View further author information
ORCID Icon,
Hagop KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Guillermo Garcia-ManeroDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Srdan VerstovsekDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; View further author information
&
Naval DaverDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
View further author information
 show all
Pages 1672-1676 | Received 08 Aug 2017, Accepted 15 Oct 2017, Published online: 09 Nov 2017

References

  • Macdonald D, Aguiar RC, Mason PJ, et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia. 1995;9:1628–1630.
  • Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol. 2010;41:461–476.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
  • Reiter A, Gotlib J. Myeloid neoplasms with eosinophilia. Blood. 2017;129:704–714.
  • Smedley D, Demiroglu A, Abdul-Rauf M, et al. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5. Neoplasia. 1999;1:349–355.
  • Ahmad I, Iwata T, Leung HY. Mechanisms of FGFR-mediated carcinogenesis. Biochim Biophys Acta. 2012;1823:850–860.
  • Patnaik MM, Gangat N, Knudson RA, et al. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution. Am J Hematol. 2010;85:238–242.
  • Gillis NK, Ball M, Zhang Q, et al. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. Lancet Oncol. 2017;18:112–121.
  • Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet. 1998;18:84–87.
  • Gaidzik VI, Teleanu V, Papaemmanuil E, et al. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia 2016;30:2282.
  • Agerstam H, Lilljebjorn H, Lassen C, et al. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer. 2007;46:635–643.
  • Illendula A, Gilmour J, Grembecka J, et al. Small molecule inhibitor of CBF?-RUNX binding for RUNX transcription factor driven cancers. EBioMedicine. 2016;8:117–131.
  • Katoh M. FGFR inhibitors: effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review). Int J Mol Med. 2016;38:3–15.
  • Daver N, Subbiah V, Asatiani E, Verstovsek S. Complete hematological and cytogenetic response in a patient with FGFR1 activated MPN receiving INCB054828. EHA 2017;1087.
  • Chase A, Bryant C, Score J, et al. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. Haematologica. 2013;98:103–106.
  • Khodadoust MS, Luo B, Medeiros BC, et al. Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia. 2016;30:947–950.
  • Kreil S, Ades L, Bommer M, et al. Limited efficacy of ponatinib in myeloproliferative neoplasms associated with FGFR1 fusion genes. Blood. 2015;126:2812.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.